We are live on ! Find out more
Group One Trading

Group One Trading Portfolio holdings

AUM $52.2B
1-Year Est. Return 104.56%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$8.46B
AUM Growth
+$1.23B
Cap. Flow
+$1.34B
Cap. Flow %
15.82%
Top 10 Hldgs %
14%
Holding
5,707
New
861
Increased
1,785
Reduced
1,764
Closed
996

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$75.7M
2
BHC icon
Bausch Health
BHC
+$46.4M
3
VNET
VNET Group
VNET
+$37.8M
4
KMI icon
Kinder Morgan
KMI
+$14.9M
5
WMB icon
Williams Companies
WMB
+$12.9M

Sector Composition

Rank Sector Weight
1 Healthcare 4.48%
2 Technology 2.06%
3 Energy 1.27%
4 Industrials 1.06%
5 Financials 1.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBS icon
3801
UBS Group
UBS
$170B
$16K ﹤0.01%
800
-6,900
-90% -$135K
UBS icon
3802
PUT
UBS Group
UBS
$170B
$16K ﹤0.01%
800
-8,500
-91% -$166K
UTHR icon
3803
United Therapeutics
UTHR
$26.3B
$16K ﹤0.01%
100
VECO icon
3804
Veeco
VECO
$2.67B
$16K ﹤0.01%
800
+6
+0.8% +$122
VECO icon
3805
PUT
Veeco
VECO
$2.67B
$16K ﹤0.01%
800
CCLP
3806
PUT
DELISTED
CSI Compressco LP
CCLP
$16K ﹤0.01%
1,400
+1,000
+250% +$13.3K
EMWP
3807
PUT
DELISTED
Eros Media World PLC
EMWP
$16K ﹤0.01%
+85
New +$24.7K
USCR
3808
CALL
DELISTED
U S Concrete, Inc.
USCR
$16K ﹤0.01%
300
+100
+50% +$5.56K
APEX
3809
PUT
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$16K ﹤0.01%
+30
New +$15.8K
PETX
3810
CALL
DELISTED
Aratana Therapeutics, Inc.
PETX
$16K ﹤0.01%
2,900
-500
-15% -$3.3K
GST
3811
CALL
DELISTED
Gastar Exploration Inc.
GST
$16K ﹤0.01%
12,500
+3,900
+45% +$5.52K
IPXL
3812
DELISTED
Impax Laboratories, Inc.
IPXL
$16K ﹤0.01%
+363
New +$14.5K
CACQ
3813
PUT
DELISTED
Caesars Acquisition Company
CACQ
$16K ﹤0.01%
2,400
+2,300
+2,300% +$17K
BEAT
3814
DELISTED
BioTelemetry, Inc.
BEAT
$16K ﹤0.01%
+1,371
New +$17.3K
CHU
3815
PUT
DELISTED
China Unicom (HONG KONG) Limited
CHU
$16K ﹤0.01%
1,300
-49,000
-97% -$617K
ATRA icon
3816
Atara Biotherapeutics
ATRA
$67.6M
$15K ﹤0.01%
22
+12
+120% +$9.08K
CLAR icon
3817
Clarus
CLAR
$125M
$15K ﹤0.01%
3,355
-7,533
-69% -$37K
CNO icon
3818
CALL
CNO Financial Group
CNO
$5B
$15K ﹤0.01%
800
-4,200
-84% -$81.6K
FOSL icon
3819
CALL
Fossil Group
FOSL
$251M
$15K ﹤0.01%
+400
New +$18.2K
HPQ icon
3820
HP
HPQ
$25.3B
$15K ﹤0.01%
1,250
-356,793
-100% -$4.57M
ITT icon
3821
CALL
ITT
ITT
$17.7B
$15K ﹤0.01%
+400
New +$15K
MDT icon
3822
CALL
Medtronic
MDT
$112B
$15K ﹤0.01%
200
-100
-33% -$7.53K
PCTY icon
3823
Paylocity
PCTY
$7.39B
$15K ﹤0.01%
358
-594
-62% -$22.8K
PLUR icon
3824
Pluri
PLUR
$17.9M
$15K ﹤0.01%
168
-38
-18% -$4.54K
PMT
3825
PUT
PennyMac Mortgage Investment
PMT
$862M
$15K ﹤0.01%
1,000
-12,300
-92% -$192K

Similar funds

Group One Trading's Q4 2015 Portfolio in Review

As of Q4 2015, Group One Trading held 5,707 positions worth $8.46B, up 17% from $7.23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Group One Trading deployed $1.34B of net new capital in Q4 2015, opening 861 new positions and adding to 1,785 existing holdings. Its largest new stake was Bausch Health: 413,358 shares worth $42M.

By sector, the portfolio is most concentrated in Healthcare at 4.5% of assets, up from 3.6% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS, an estimated $17M trimmed.

  • Group One Trading's largest Q4 2015 buy was Bausch Health: 413,358 shares worth $42M.
  • Group One Trading added most to Allergan plc in Q4 2015, an estimated $75.7M increase.
  • Group One Trading's biggest Q4 2015 reduction was QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS, cutting an estimated $17M.
  • Group One Trading fully exited H&R Block in Q4 2015, selling an estimated $15.3M.
  • Group One Trading's ten largest holdings make up 14% of its $8.46B portfolio in Q4 2015.
  • Group One Trading opened 861 new positions and closed 996 in Q4 2015.
  • Group One Trading's portfolio value rose 17% quarter-over-quarter to $8.46B.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.